Nadya So / Shutterstock.com
10 July 2025NewsEuropeMarisa Woutersen

Startups toolkit: Why investors want more than patents

For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, Marisa Woutersen explores how they can succeed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
29 October 2024   Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.
Big Pharma
24 June 2021   Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.
Europe
8 February 2021   Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.

More on this story

Americas
29 October 2024   Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.
Big Pharma
24 June 2021   Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.
Europe
8 February 2021   Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.

More on this story

Americas
29 October 2024   Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.
Big Pharma
24 June 2021   Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.
Europe
8 February 2021   Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.